{"SPADE_UN_24478": {"Sequence Information": {"Peptide Name": "EBOV-GP (610-639)[E611G,P612I,H613E,W615L,T616S,T620K,Q625K]-C", "Sequence": "IGIEDLSKNIKDKIDKIIHDFVDKTLPDQGX", "Sequence Length": 31, "Biological Activity": ["Antiviral", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Virus entry", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "Q05320", "uniprotUrl": "http://www.uniprot.org/uniprot/Q05320", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.", "Pubmed ID": "31473342", "Reference": "Antiviral Res. 2019;171:104592", "Author": "Pessi A, Bixler SL, Soloveva V, Radoshitzky S, et al.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31473342"}], "SPADE ID": "SPADE_UN_24478", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_24475", "Similarity": 0.9230769230769231, "Sequence": "DWTKNIKDKIDKIIHDFVDKTLPDQG"}, {"SPADE_ID": "SPADE_UN_24476", "Similarity": 0.9230769230769231, "Sequence": "DWTKNIKDKIDKIIHDFVDKTLPDQG"}, {"SPADE_ID": "SPADE_UN_24474", "Similarity": 0.9, "Sequence": "DWTKNIKDKIDKIIHDFVDK"}], "Hemolytic Activity": "Human embryonic kidney HEK293T cells:50% Cytotoxicity=>=25 µM", "Target Organism": "Ebola virus EBOV(IC50 I=18.47±4.64µM),Ebola virus EBOV(IC90 I=69.49µM),Human cervical carcinoma HeLa(50-60% Cytotoxicity=>25µM),Ebola virus EBOV-GP PsV(IC50 E=4.02±1.13µM),Ebola virus EBOV-GP PsV(IC90=20.22µM),Marburg virus MARV-GP PsV(IC50 E=4.66±0.59µM),Marburg virus MARV-GP PsV(IC90=15.13µM)"}}}